Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2018; 29(17): 2283-2287
DOI: 10.1055/s-0037-1610271
DOI: 10.1055/s-0037-1610271
letter
Copper-Catalyzed Synthesis of Substituted 4-Acylpyrazole Derivatives through a Cascade Transformation from N-Propargylic Sulfonylhydrazones and Diaryliodonium Salts
Authors
Financial support from the National Natural Science Foundation of China (no. 21772166) and the NFFTBS (no. J1310024) is gratefully acknowledged.
Further Information
Publication History
Received: 02 July 2018
Accepted after revision: 14 August 2018
Publication Date:
03 September 2018 (online)

Abstract
A concise strategy for the synthesis of substituted 4-acylpyrazole derivatives from N-propargylic sulfonylhydrazones and diaryliodonium salts has been developed. The pyrazole derivatives are formed through a five-step cascade sequence that includes intramolecular cyclization, hydroxylation, elimination, copper-catalyzed aerobic oxidation, and intramolecular rearrangement.
Key words
propargylic sulfonylhydrazones - diaryliodonium salts - cascade transformation - acylpyrazolesSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1610271.
- Supporting Information (PDF) (opens in new window)
-
References and Notes
- 1a Bekhit AA. Abdel-Aziem T. Bioorg. Med. Chem. 2004; 12: 1935
- 1b Manna F. Chimenti F. Fioravanti R. Bolasco A. Secci D. Chimenti P. Ferlini C. Scambia G. Bioorg. Med. Chem. Lett. 2005; 15: 4632
- 1c Fahmy HH. Khalifa NM. Ismail MM. El-Sahrawy HM. Nossier ES. Molecules 2016; 21: 271
- 1d Venância Faria J. Fazolin Vegi P. Carvalho Miguita AG. Silva Dos Santos M. Boechat N. Rolim Bernardino AM. Bioorg. Med. Chem. 2017; 25: 5891
- 2 Ralph JM. Faitg TH. Silva DJ. Feng Y. Blackledge CW. Adams JL. Tetrahedron Lett. 2009; 50: 1377
- 3a Schmink JR. Krska SW. J. Am. Chem. Soc. 2011; 133: 19574
- 3b Weires NA. Baker EL. Garg NK. Nat. Chem. 2016; 8: 75
- 3c Lian Z. Nielsen DU. Lindhardt AT. Daasbjerg K. Skrydstrup T. Nat. Commun. 2016; 7: 13782
- 4 Bagley MC. Davis T. Dix MC. Murziani PG. Rokicki MJ. Kipling D. Bioorg. Med. Chem. Lett. 2008; 18: 3745
- 5 Nishiwaki N. Matsushima K. Chatani M. Tamura M. Ariga M. Synlett 2004; 703
- 6 Taydakov I. Krasnoselskiy S. Synthesis 2013; 45: 2188
- 7 Tian M. Shi X. Zhang X. Fan X. J. Org. Chem. 2017; 82: 7363
- 8 Young TL. Young KC. J. Org. Chem. 2008; 73: 4698
- 9 Zhu Y. Lu W.-T. Sun H.-C. Zhan Z.-P. Org. Lett. 2013; 15: 4146
- 10 Wen JJ. Tang HT. Xiong K. Ding ZC. Zhan ZP. Org. Lett. 2014; 16: 5940
- 11 Wen J.-J. Ding C.-K. Ding Z.-C. Li T. Zhan Z.-P. Eur. J. Org. Chem. 2015; 2015: 5230
- 12a Merritt EA. Olofsson B. Angew. Chem. Int. Ed. 2009; 48: 9052
- 12b Sasaki T. Miyagi K. Moriyama K. Togo H. Org. Lett. 2016; 18: 944
- 12c Pérez-Saavedra B. Vázquez-Galiñanes N. Saá C. Fañanás-Mastral M. ACS Catal. 2017; 7: 6104
- 12d Miralles N. Romero RM. Fernández E. Muñiz K. Chem. Commun. 2015; 51: 14068
- 12e Huang Z. Sam QP. Dong G. Chem. Sci. 2015; 6: 5491
- 12f Wang G. Chen C. Peng J. Chem. Commun. 2016; 52: 10277
- 12g Wen L.-R. Shen Q.-Y. Guo W.-S. Li M. Org. Chem. Front. 2016; 3: 870
- 12h Ma X.-P. Li K. Wu S.-Y. Liang C. Su G.-F. Mo D.-L. Green Chem. 2017; 19: 5761
- 12i Guo J. Dong S. Zhang Y. Kuang Y. Liu X. Lin L. Feng X. Angew. Chem. Int. Ed. 2013; 52: 10245
- 12j Gao P. Guo W. Xue J. Zhao Y. Yuan Y. Xia Y. Shi Z. J. Am. Chem. Soc. 2015; 137: 12231
- 13 Chen B. Hou X.-L. Li Y.-X. Wu Y.-D. J. Am. Chem. Soc. 2011; 133: 7668
- 14 Pyrazoles 3a–m; General Procedure A 10 mL round-bottomed flask was charged with the appropriate N-propargylic sulfonylhydrazone 1 (0.5 mmol), diaryliodonium salt 2 (0.75 mmol), and Cu(OTf)2 (18.1 mg, 0.05 mmol). Undried DBE (5 mL) was added, and the mixture was stirred at 80 °C in air until the reaction was complete (TLC). The solvent was removed under vacuum, and the crude residue was purified by column chromatography (silica gel, eluent: petroleum ether/EtOAc = 30/1). (1,3-Diphenyl-1H-pyrazol-4-yl)(phenyl)methanone (3a) White solid; yield: 92 mg (57%); mp 117–119 °C. 1H NMR (500 MHz, CDCl3): δ = 7.34–7.37 (m, 2 H), 7.43 (t, J = 7.7 Hz, 2 H), 7.50–7.56 (m, 4 H), 7.74–7.77 (m, 2 H), 7.80–7.88 (m, 5 H), 8.31 (s, 1 H). 13C NMR (125 MHz, CDCl3): δ = 119.6, 121.2, 127.5, 128.1, 128.3, 128.6, 128.9, 129.4, 129.6, 132.1, 132.2, 132.6, 138.9, 139.2, 154.0, 190.0. HRMS (ESI): m/z [M + Na] calcd for C22H16N2NaO: 347.1155; found: 347.1160. [3-(4-Bromophenyl)-1-(4-tolyl)-1H-pyrazol-4-yl](phenyl)-methanone (3b) White solid; yield: 102 mg (49%); mp 139–141 °C. 1H NMR (400 MHz, CDCl3): δ = 2.43 (s, 3 H), 7.30 (d, J = 8.0 Hz, 2 H), 7.44–7.52 (m, 4 H), 7.58 (t, J = 7.3 Hz, 1 H), 7.64–7.72 (m, 4 H), 7.86 (d, J = 7.7 Hz, 2 H), 8.23 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 21.0, 119.5, 120.8, 122.8, 128.4, 129.4, 130.1, 130.5, 131.1, 131.2, 132.5, 132.6, 136.8, 137.7, 138.9, 152.6, 189.7. HRMS (ESI): m/z [M + Na] calcd for C23H17BrN2NaO: 439.0416 and 441.0396; found: 439.0419 and 441.0399.